| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1995PNAS...9210119R |
| P356 | DOI | 10.1073/PNAS.92.22.10119 |
| P932 | PMC publication ID | 40747 |
| P698 | PubMed publication ID | 7479737 |
| P5875 | ResearchGate publication ID | 15718838 |
| P2093 | author name string | G Migliaccio | |
| C E Stevens | |||
| P Rubinstein | |||
| J W Adamson | |||
| P E Taylor | |||
| A R Migliaccio | |||
| R E Rosenfield | |||
| L Dobrila | |||
| P2860 | cites work | Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells | Q33858964 |
| Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling | Q34668125 | ||
| Successful hematopoietic reconstitution with transplantation of erythrocyte-depleted allogeneic human umbilical cord blood cells in a child with leukemia | Q35236878 | ||
| Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults | Q37600205 | ||
| Collection, Cryopreservation and Subsequent Viability of Haemopoietic Stem Cells Intended for Treatment of Chronic Granulocytic Leukaemia in Blast-Cell Transformation | Q39217007 | ||
| Stored placental blood for unrelated bone marrow reconstitution | Q40708879 | ||
| Adverse reactions in patients transfused with cryopreserved marrow | Q40747259 | ||
| Unrelated placental blood for bone marrow reconstitution: organization of the placental blood program. | Q41055865 | ||
| Transplantation of umbilical cord blood after myeloablative therapy: analysis of engraftment | Q43676721 | ||
| Clinical toxicity of cryopreserved bone marrow graft infusion | Q44675620 | ||
| Growth of human umbilical-cord blood in longterm haemopoietic cultures | Q44788693 | ||
| Serology for automated cytotoxicity assays. Contrast fluorescence test. | Q50963991 | ||
| Osmotic stress as a mechanism of freezing injury | Q57124529 | ||
| HLA-mismatched cord-blood transplantation in a patient with advanced leukemia | Q68124648 | ||
| The use of umbilical cord blood in mismatched related and unrelated hemopoietic stem cell transplantation | Q72233979 | ||
| Collection, separation and cryopreservation of umbilical cord blood for use in transplantation | Q72521850 | ||
| Umbilical cord blood banking: evaluation of the collection procedure and of CFU-GM content | Q72706923 | ||
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bone marrow | Q546523 |
| cryopreservation | Q1144664 | ||
| P304 | page(s) | 10119-10122 | |
| P577 | publication date | 1995-10-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution | |
| P478 | volume | 92 |
| Q37674034 | "No wash" albumin-dextran dilution for double-unit cord blood transplantation is safe with high rates of sustained donor engraftment |
| Q35018038 | A "no-wash" albumin-dextran dilution strategy for cord blood unit thaw: high rate of engraftment and a low incidence of serious infusion reactions |
| Q35285087 | A comparison of immune reconstitution and graft-versus-host disease following myeloablative conditioning versus reduced toxicity conditioning and umbilical cord blood transplantation in paediatric recipients |
| Q33610841 | A history of haemopoietic cell transplantation |
| Q45714676 | A non-rotational, computer-controlled suspension bioreactor for expansion of umbilical cord blood mononuclear cells. |
| Q53119236 | A novel filtration method for cord blood processing using a polyester fabric filter. |
| Q50494724 | A novel method of CD34+ cell separation from umbilical cord blood. |
| Q37627281 | A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases |
| Q44733418 | A pilot study of reduced intensity conditioning and allogeneic stem cell transplantation from unrelated cord blood and matched family donors in children and adolescent recipients |
| Q84983778 | A pilot study of reduced toxicity conditioning with BU, fludarabine and alemtuzumab before the allogeneic hematopoietic SCT in children and adolescents |
| Q37424438 | Adult dual umbilical cord blood transplantation using myeloablative total body irradiation (1350 cGy) and fludarabine conditioning |
| Q40122835 | Adverse reactions during stem cell infusion in children treated with autologous and allogeneic stem cell transplantation |
| Q33769696 | Allogeneic transplantation from donors other than HLA-identical siblings |
| Q35058540 | Alloreactive killer cells: hindrance and help for haematopoietic transplants |
| Q35112222 | Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts |
| Q49278964 | An international survey of unrelated umbilical cord blood banking |
| Q38841289 | An update on ABO incompatible hematopoietic progenitor cell transplantation |
| Q38841189 | An update on methods for cryopreservation and thawing of hemopoietic stem cells |
| Q43782772 | Analysis of 120 pediatric patients with nonmalignant disorders transplanted using unrelated plasma-depleted or -reduced cord blood |
| Q37330968 | Analysis of risk factors influencing outcomes after cord blood transplantation in children with juvenile myelomonocytic leukemia: a EUROCORD, EBMT, EWOG-MDS, CIBMTR study |
| Q48197629 | Assessing the toxic effects of DMSO on cord blood to determine exposure time limits and the optimum concentration for cryopreservation. |
| Q50680795 | Assessment of cord blood hematopoietic cell parameters before and after cryopreservation. |
| Q31048572 | Assessment of cord blood unit characteristics on the day of transplant: comparison with data issued by cord blood banks |
| Q44606441 | Association of CD26 with CD45RA outside lipid rafts attenuates cord blood T-cell activation |
| Q50508394 | Association of CFU-Mk with total colony-forming units in thawed cord blood units. |
| Q50658293 | Association of cord blood platelet characteristics and hematopoietic progenitor cells. |
| Q33722031 | Autologous Cord Blood Infusions Are Safe and Feasible in Young Children with Autism Spectrum Disorder: Results of a Single-Center Phase I Open-Label Trial. |
| Q48033629 | Automated washing of human progenitor cells: evaluation of apoptosis and cell necrosis |
| Q38880448 | Automatic washing of thawed haematopoietic progenitor cell grafts: a preclinical evaluation |
| Q53191735 | Bcr-Abl dependent post-transcriptional activation of NME2 expression is a specific and common feature of chronic myeloid leukemia. |
| Q73599619 | Bigger is better: maternal and neonatal predictors of hematopoietic potential of umbilical cord blood units |
| Q38796125 | Biobanking of Human Mesenchymal Stem Cells: Future Strategy to Facilitate Clinical Applications |
| Q64272068 | Bioinspired Preservation of Natural Killer Cells for Cancer Immunotherapy |
| Q59640188 | CD34+ progenitors are reproducibly recovered in thawed umbilical grafts and positively influence haematopoietic reconstitution after transplantation |
| Q44518380 | CD4+ and CD8+ T lymphocyte regeneration after anti-retroviral therapy in HIV-1-infected children and adult patients |
| Q80525521 | Cardiovascular toxicity of cryopreserved cord blood cell infusion |
| Q36003215 | Cellular immune therapy for refractory cancers: novel therapeutic strategies |
| Q53458386 | Characterization of phenotypically distinct B-cell subsets and receptor-stimulated mitogen-activated protein kinase activation in human cord blood B cells. |
| Q37666677 | Clinical grade adult stem cell banking |
| Q60313644 | Clinical-grade cell purification from thawed cord blood: an example of translational research |
| Q28743568 | Clinical-grade generation of active NK cells from cord blood hematopoietic progenitor cells for immunotherapy using a closed-system culture process |
| Q51026575 | Collection strategies and cryopreservation of umbilical cord blood. |
| Q37043852 | Collection, Separation, Enumeration and Cryopreservation of Umbilical Cord Blood Haematopoietic Stem Cells - An Experimental Study |
| Q57107041 | Collection, processing and cryopreservation of umbilical cord blood for unrelated transplantation |
| Q36391489 | Comparative Analysis of the Immunomodulatory Properties of Equine Adult-Derived Mesenchymal Stem Cells(). |
| Q92417109 | Comparison and correlation among in vitro and in vivo assays to assess cord blood quality according to delivery temperature and time after collection |
| Q51801838 | Comparison of human umbilical cord blood processing with or without hydroxyethyl starch. |
| Q36080841 | Comparison of pre-cryopreserved and post-thaw-and-wash-nucleated cell count on major outcomes following unrelated cord blood transplant in children |
| Q30366297 | Complement fragment 3a priming of umbilical cord blood progenitors: safety profile. |
| Q33455005 | Cord Blood Banking and Transplantation in China: A Ten Years Experience of a Single Public Bank |
| Q38142167 | Cord Blood Transplantation: Can We Make it Better? |
| Q44140260 | Cord blood banking activities at a university hospital in northeast Mexico: an 8-year experience |
| Q47958862 | Cord blood banking and quality issues |
| Q53352613 | Cord blood banking and transplant in Europe. Eurocord. |
| Q37607968 | Cord blood banking for clinical transplantation |
| Q33445721 | Cord blood from collection to expansion: feasibility in a regional blood bank |
| Q75251177 | Cord blood stem cell banking and transplantation |
| Q45332228 | Cord blood stem cell banking: a snapshot of the Italian situation |
| Q36163589 | Cord blood units with low CD34+ cell viability have a low probability of engraftment after double unit transplantation |
| Q80486498 | Coronary artery spasm after infusion of cryopreserved cord blood cells |
| Q35080565 | Cryogenic transmission electron microscopy nanostructural study of shed microparticles |
| Q37049533 | Cryopreservation of Bone Marrow Mononuclear Cells Alters Their Viability and Subpopulation Composition but Not Their Treatment Effects in a Rodent Stroke Model |
| Q43603137 | Cryopreservation of HPCs for clinical use. |
| Q64958733 | Cryopreservation of Hematopoietic Stem Cells: Emerging Assays, Cryoprotectant Agents, and Technology to Improve Outcomes. |
| Q34939259 | Cryopreservation of Human Stem Cells for Clinical Application: A Review |
| Q36531157 | Cryopreservation of hematopoietic and non-hematopoietic stem cells |
| Q34607937 | Cryopreservation of hematopoietic stem cells |
| Q80007241 | Cryopreservation of human blood products |
| Q43979630 | Cryopreservation of mouse adipose tissue-derived stem/progenitor cells. |
| Q41979600 | Cryopreservation of stromal vascular fraction of adipose tissue in a serum-free freezing medium |
| Q26738594 | Cryopreservation of testicular tissue or testicular cell suspensions: a pivotal step in fertility preservation |
| Q34182093 | Cryopreservation of umbilical cord blood: 1. Osmotically inactive volume, hydraulic conductivity and permeability of CD34(+) cells to dimethyl sulphoxide |
| Q44352994 | Cryopreservation of umbilical cord blood: 2. Tolerance of CD34(+) cells to multimolar dimethyl sulphoxide and the effect of cooling rate on recovery after freezing and thawing |
| Q38709791 | Cryopreservation: Vitrification and Controlled Rate Cooling |
| Q57106010 | Cryopreserved human haematopoietic stem cells retain engraftment potential after extended (5-14 years) cryostorage |
| Q45386783 | Current and historical perspectives on methodological flaws in processing umbilical cord blood |
| Q38217398 | Current thawing and infusion practice of cryopreserved cord blood: the impact on graft quality, recipient safety, and transplantation outcomes |
| Q40101845 | Cytomegalovirus viral load in cord blood and impact of congenital infection on markers of hematopoietic progenitor cell potency |
| Q36635075 | Developing a clinical-grade cryopreservation protocol for human testicular tissue and cells |
| Q48324284 | Development and testing of a stepwise thaw and dilute protocol for cryopreserved umbilical cord blood units |
| Q36897147 | Development and validation of a rapid, aldehyde dehydrogenase bright-based cord blood potency assay |
| Q33444165 | Development of a district Cord Blood Bank: a model for cord blood banking in the National Health Service |
| Q42177747 | Development of a reliable low-cost controlled cooling rate instrument for the cryopreservation of hematopoietic stem cells |
| Q43556876 | Dextran sedimentation in a semi-closed system for the clinical banking of umbilical cord blood |
| Q37277064 | Differences in quality between privately and publicly banked umbilical cord blood units: a pilot study of autologous cord blood infusion in children with acquired neurologic disorders |
| Q48480090 | Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study |
| Q39407130 | Distinct functional effects for dynamin 3 during megakaryocytopoiesis |
| Q33456839 | Dominant unit CD34+ cell dose predicts engraftment after double-unit cord blood transplantation and is influenced by bank practice |
| Q33952705 | Donor-derived second hematologic malignancies after cord blood transplantation |
| Q34451427 | Double umbilical cord blood transplantation with reduced intensity conditioning and sirolimus-based GVHD prophylaxis. |
| Q34162647 | Double unrelated reduced-intensity umbilical cord blood transplantation in adults |
| Q33425856 | Durable engraftment and correction of hematological abnormalities in children with congenital amegakaryocytic thrombocytopenia following myeloablative umbilical cord blood transplantation |
| Q37309541 | Dynamin 3 participates in the growth and development of megakaryocytes |
| Q36141575 | Early lymphocyte recovery and outcomes after umbilical cord blood transplantation (UCBT) for hematologic malignancies |
| Q53535911 | Early proliferation of umbilical cord blood cells from premature neonates. |
| Q46341382 | Effect of Autologous Cord Blood Infusion on Motor Function and Brain Connectivity in Young Children with Cerebral Palsy: A Randomized, Placebo-Controlled Trial. |
| Q34033553 | Effect of conditioning regimen intensity on acute myeloid leukemia outcomes after umbilical cord blood transplantation |
| Q35177492 | Effect of cord blood processing on transplantation outcomes after single myeloablative umbilical cord blood transplantation |
| Q44328122 | Effect of recombinant human deoxyribonuclease on the expression of cell adhesion molecules of thawed and processed cord blood hematopoietic progenitors |
| Q64889585 | Effects of Cryopreservation Duration on the Outcome of Single-Unit Cord Blood Transplantation. |
| Q57173702 | Electrophysiological Biomarkers Predict Clinical Improvement in an Open-Label Trial Assessing Efficacy of Autologous Umbilical Cord Blood for Treatment of Autism |
| Q53251087 | Engraftment for CD34 selected stem cell products is not compromised by cryopreservation. |
| Q81042755 | Engraftment kinetics of human CD34+ cells from cord blood and mobilized peripheral blood co-transplanted into NOD/SCID mice |
| Q36192813 | Enhancing engraftment of cord blood cells via insight into the biology of stem/progenitor cell function |
| Q53041684 | Essential requirements for setting up a stem cell processing laboratory. |
| Q39540582 | Evaluation of a xeno-free protocol for long-term cryopreservation of cord blood cells. |
| Q46430954 | Evaluation of ex vivo expansion and engraftment in NOD-SCID mice of umbilical cord blood CD34+ cells using the DIDECO "Pluricell System". |
| Q60313657 | Evaluation of the effect of cryopreservation on ex vivo expansion of hematopoietic progenitors from cord blood |
| Q33344249 | Ex vivo expansion of megakaryocyte progenitors from cryopreserved umbilical cord blood. A potential source of megakaryocytes for transplantation |
| Q36681962 | Ex vivo expansion of umbilical cord blood stem cells for transplantation: growing knowledge from the hematopoietic niche |
| Q37995979 | Ex vivo expansion of umbilical cord blood: where are we? |
| Q36675920 | Expansion of engrafting human hematopoietic stem/progenitor cells in three-dimensional scaffolds with surface-immobilized fibronectin. |
| Q33504681 | Expansion of megakaryocyte progenitors from human umbilical cord blood using a new two-step separation procedure |
| Q30538380 | Expression of plasma membrane receptor genes during megakaryocyte development |
| Q50563873 | Factors affecting banking quality of umbilical cord blood for transplantation. |
| Q58814355 | Factors affecting lymphocyte subset reconstitution after either related or unrelated cord blood transplantation in children - a Eurocord analysis |
| Q85307404 | Factors which can influence the quality related to cell viability of the umbilical cord blood units |
| Q33364322 | Fibroblast growth factor and ex vivo expansion of hematopoietic progenitor cells |
| Q42355455 | First experience of hematopoietic stem cell transplantation treatment of Shwachman-Diamond syndrome using unaffected HLA-matched sibling donor produced through preimplantation HLA typing. |
| Q41770362 | Fludarabine, melphalan, thiotepa and anti-thymocyte globulin conditioning for unrelated cord blood transplant. |
| Q37608438 | Generation of Immunodeficient Mice Bearing Human Immune Systems by the Engraftment of Hematopoietic Stem Cells |
| Q35180417 | Genetic modification of human hematopoietic cells: preclinical optimization of oncoretroviral-mediated gene transfer for clinical trials |
| Q37715706 | Going straight to the point: intra-BM injection of hematopoietic progenitors |
| Q50490940 | Growth of erythroid cells from thawed unseparated cord blood in vitro without exogenous erythropoietin. |
| Q35794126 | HLA mismatch direction in cord blood transplantation: impact on outcome and implications for cord blood unit selection |
| Q84589607 | Haemopoietic Lineage Sensitivity and Individual Susceptibility to PCB126: Relation to Glutathione S-transferase mu |
| Q36304593 | Harnessing the therapeutic potential of myogenic stem cells. |
| Q35571628 | Hematopoietic SCT with cryopreserved grafts: adverse reactions after transplantation and cryoprotectant removal before infusion |
| Q78825180 | Hematopoietic recovery after unrelated umbilical cord-blood allogeneic transplantation in adults treated with in vivo stem cell factor (R-MetHuSCF) and filgrastim administration |
| Q35674530 | Hematopoietic stem cell transplantation using umbilical cord blood progenitors: review of current clinical results |
| Q33361807 | High sensitivity of megakaryocytic progenitor cells contained in placental/umbilical cord blood to the stresses during cryopreservation |
| Q57808603 | High-efficiency volume reduction of cord blood using pentastarch |
| Q37391113 | High-resolution HLA matching in double-umbilical-cord-blood reduced-intensity transplantation in adults |
| Q37607988 | History of cord blood transplantation |
| Q53437646 | History of haematopoietic stem-cell transplantation. |
| Q34707580 | How I treat: the selection and acquisition of unrelated cord blood grafts |
| Q38946756 | How transplant centers deal with the dextran shortage: recommendations for comparing alternatives |
| Q50452316 | How we handled the dextran shortage: an alternative washing or dilution solution for cord blood infusions. |
| Q90419997 | Human Leukocyte Antigen and Red Blood Cells Impact Umbilical Cord Blood CD34+ Cell Viability after Thawing |
| Q74505231 | Human stem-progenitor cells from neonatal cord blood have greater hematopoietic expansion capacity than those from mobilized adult blood |
| Q33892749 | Human umbilical cord blood banking and transplantation: a state of the art. |
| Q47311356 | Hydrogel Encapsulation Facilitates Rapid-Cooling Cryopreservation of Stem Cell-Laden Core-Shell Microcapsules as Cell-Biomaterial Constructs |
| Q39811692 | Immunomagnetic selection of purified monocyte and lymphocyte populations from peripheral blood mononuclear cells following cryopreservation |
| Q50885057 | Impact of Delayed Infusion Time in Umbilical Cord Blood Transplantation. |
| Q38833975 | Impact of Graft-Recipient ABO Compatibility on Outcomes after Umbilical Cord Blood Transplant for Nonmalignant Disease |
| Q39721991 | Impact of cord blood banking technologies on clinical outcome: a Eurocord/Cord Blood Committee (CTIWP), European Society for Blood and Marrow Transplantation and NetCord retrospective analysis. |
| Q49133811 | Impact of length of cryopreservation and origin of cord blood units on hematologic recovery following cord blood transplantation |
| Q35230664 | Impact of long-term cryopreservation on single umbilical cord blood transplantation outcomes |
| Q36794125 | Impact of selection of cord blood units from the United States and swiss registries on the cost of banking operations |
| Q44609641 | In utero or ex utero cord blood collection: which is better? |
| Q54518492 | In vitro hepatic differentiation of human umbilical cord blood and bone marrow cells. |
| Q36715531 | In vivo DPP-4 inhibition to enhance engraftment of single-unit cord blood transplants in adults with hematological malignancies |
| Q36263802 | India's first public cord blood repository - looking back and moving forward |
| Q35786957 | Indirect evidence that maternal microchimerism in cord blood mediates a graft-versus-leukemia effect in cord blood transplantation |
| Q34754318 | Influence of infused cell dose and HLA match on engraftment after double-unit cord blood allografts |
| Q33457345 | Influence of maternal, infant, and collection characteristics on high-quality cord blood units in Guangzhou Cord Blood Bank |
| Q34144161 | Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics |
| Q80501587 | Infusion of unwashed umbilical cord blood stem cells after thawing for allogeneic transplantation |
| Q37505684 | Intra-BM injection to enhance engraftment after myeloablative umbilical cord blood transplantation with two partially HLA-matched units. |
| Q36316441 | Intrabone transplant of cord blood stem cells establishes a local engraftment store: a functional PET/FDG study. |
| Q34449885 | Is there an expiration date for a cord blood unit in storage? |
| Q54388224 | Isolation and characterization of mesenchymal stem cells from human umbilical cord blood: reevaluation of critical factors for successful isolation and high ability to proliferate and differentiate to chondrocytes as compared to mesenchymal stem cel |
| Q42859180 | Isolation and expansion of oligodendrocyte progenitor cells from cryopreserved human umbilical cord blood |
| Q50210306 | Isolation of mesenchymal stromal/stem cells from cryopreserved umbilical cord blood cells. |
| Q54096114 | Kinetics of T-cell development of umbilical cord blood transplantation in severe T-cell immunodeficiency disorders. |
| Q43536885 | Kinetics of myeloid and lymphocyte recovery and infectious complications after unrelated umbilical cord blood versus HLA-matched unrelated donor allogeneic transplantation in adults |
| Q50494572 | Long term cryostorage of UC blood units: ability of the integral segment to confirm both identity and hematopoietic potential |
| Q43954407 | Loss of integrity of umbilical cord blood unit freezing bags: description and consequences |
| Q50455895 | Loss of the ability to generate large burst-forming unit-like megakaryocytic colonies from thawed cord blood in semisolid cultures after short term suspension culture |
| Q35854789 | Low dose total body irradiation followed by allogeneic lymphocyte infusion for refractory hematologic malignancy--an updated review |
| Q27302331 | MRI tracking of FePro labeled fresh and cryopreserved long term in vitro expanded human cord blood AC133+ endothelial progenitor cells in rat glioma |
| Q36092724 | Mesenchymal stem cells engineered for cancer therapy |
| Q45713916 | Microbial contamination of cord blood stem cells |
| Q48636372 | Milestones in umbilical cord blood transplantation |
| Q37617110 | Mononuclear cells from a rare blood donor, after freezing under good manufacturing practice conditions, generate red blood cells that recapitulate the rare blood phenotype |
| Q36517880 | Myeloablative transplantation using either cord blood or bone marrow leads to immune recovery, high long-term donor chimerism and excellent survival in chronic granulomatous disease |
| Q37209082 | Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplant depends on transplantation conditioning intensity |
| Q57807747 | No proinflammatory signature in CD34+ hematopoietic progenitor cells in multiple sclerosis patients |
| Q78493189 | Nonobese diabetic-severe combined immunodeficient mice transplantation of volume-reduced and thawed umbilical cord blood transplants following closed-system immunomagnetic cell selection |
| Q33642298 | Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution |
| Q26772216 | Novel Techniques for Ex Vivo Expansion of Cord Blood: Clinical Trials |
| Q38747929 | Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies |
| Q33457094 | Optimal method for collection of umbilical cord blood: an Egyptian trial for a public cord blood bank |
| Q53028580 | Optimization of the freezing process for hematopoietic progenitor cells: effect of precooling, initial dimethyl sulfoxide concentration, freezing program, and storage in vapor-phase or liquid nitrogen on in vitro white blood cell quality. |
| Q36034862 | Optimizing cord blood collections: Assessing the role of maternal and neonatal factors |
| Q33449843 | Outcomes of 122 diverse adult and pediatric cord blood transplant recipients from a large cord blood bank |
| Q34247841 | Outcomes of a program to evaluate mother and baby 6 months after umbilical cord blood donation |
| Q80387211 | Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failure |
| Q80459448 | Outcomes of transplantation in children with acute leukaemia |
| Q44859645 | Outcomes of unrelated cord blood transplantation in pediatric recipients |
| Q23918117 | Peptides from the amino terminal mdm-2-binding domain of p53, designed from conformational analysis, are selectively cytotoxic to transformed cells |
| Q42137721 | Pharmacological preconditioning for short-term ex vivo expansion of human umbilical cord blood hematopoietic stem cells by filgrastim |
| Q36938847 | Phase I/II Trial of StemRegenin-1 Expanded Umbilical Cord Blood Hematopoietic Stem Cells Supports Testing as a Stand-Alone Graft |
| Q38743140 | Phase II study of intrabone single unit cord blood transplantation for hematological malignancies |
| Q36395129 | Phase II trial of parathyroid hormone after double umbilical cord blood transplantation. |
| Q58449850 | Pilot trial of risk-adapted cyclophosphamide intensity based conditioning and HLA matched sibling and unrelated cord blood stem cell transplantation in newly diagnosed pediatric and adolescent recipients with acquired severe aplastic anemia |
| Q38210864 | Plasma-depleted versus red cell-reduced umbilical cord blood |
| Q73388222 | Postpartum umbilical cord blood collection for transplantation: a comparison of three methods |
| Q33381227 | Posttransplant autoimmune hemolytic anemia and other autoimmune cytopenias are increased in very young infants undergoing unrelated donor umbilical cord blood transplantation |
| Q84661887 | Pre-transplant manipulation processing of umbilical cord blood units: Efficacy of Rubinstein's thawing technique used in 40 transplantation procedures |
| Q44431127 | Preclinical evaluation of an automated closed fluid management device: CytomateTM, for washing out DMSO from hematopoietic stem cell grafts after thawing |
| Q33340497 | Preclinical ex vivo expansion of cord blood hematopoietic stem and progenitor cells: duration of culture; the media, serum supplements, and growth factors used; and engraftment in NOD/SCID mice |
| Q53402660 | Preclinical study design for evaluation of stem cell-derived cellular therapy products: a pathologist's perspective. |
| Q34164805 | Preinfusion variables predict the predominant unit in the setting of reduced-intensity double cord blood transplantation |
| Q34094348 | Preserving human cells for regenerative, reproductive, and transfusion medicine |
| Q41826765 | Prevention of graft-versus-host disease by adoptive T regulatory therapy is associated with active repression of peripheral blood Toll-like receptor 5 mRNA expression |
| Q36092021 | Promising progression-free survival for patients low and intermediate grade lymphoid malignancies after nonmyeloablative umbilical cord blood transplantation |
| Q56609915 | Prompt and durable engraftment in two older adult patients with high risk chronic myelogenous leukemia (CML) using ex vivo expanded and unmanipulated unrelated umbilical cord blood |
| Q37059231 | Qualitative and quantitative cell recovery in umbilical cord blood processed by two automated devices in routine cord blood banking: a comparative study |
| Q42482133 | Quality of long-term cryopreserved umbilical cord blood units for hematopoietic cell transplantation |
| Q53574326 | Quality of umbilical cord blood CD34+ cells in a double-compartment freezing bag cryopreserved without a rate-controlled programmed freezer. |
| Q33452269 | Quality rather than quantity: the cord blood bank dilemma |
| Q83113176 | Quality-assessments of characteristics of placental/umbilical cord blood associated with maternal age- and parity-related factor |
| Q45933467 | Racial and ethnic composition of volunteer cord blood donors: comparison with volunteer unrelated marrow donors. |
| Q42784084 | Re: Stem cells derived from cord blood in transplantation and regenerative medicine. Further phenomena |
| Q33455702 | Reasons for exclusion of 6820 umbilical cord blood donations in a public cord blood bank |
| Q37928443 | Red blood cell-incompatible allogeneic hematopoietic progenitor cell transplantation |
| Q57216387 | Reduced intensity allogeneic umbilical cord blood transplantation in children and adolescent recipients with malignant and non-malignant diseases |
| Q44972667 | Reduced intensity haemopoietic stem-cell transplantation for treatment of non-malignant diseases in children |
| Q37085064 | Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor |
| Q37415942 | Reexposure of cord blood to noninherited maternal HLA antigens improves transplant outcome in hematological malignancies |
| Q37414733 | Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units |
| Q40582613 | Repeated autologous umbilical cord blood infusions are feasible and had no acute safety issues in young babies with congenital hydrocephalus |
| Q43611651 | Results of an unrelated transplant search strategy using partially HLA-mismatched cord blood as an immediate alternative to HLA-matched bone marrow |
| Q36969812 | Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies |
| Q34326722 | Results of unrelated umbilical cord blood hematopoietic stem cell transplantation |
| Q54637432 | Risk of viral transmission via bone marrow progenitor cells versus umbilical cord blood hematopoietic stem cells in bone marrow transplantation. |
| Q39449623 | Role of Mesenchymal Stem Cells in Cancer Development and Their Use in Cancer Therapy |
| Q98289652 | Role of Nrf2 in Lipopolysaccharide-Induced Acute Kidney Injury: Protection by Human Umbilical Cord Blood Mononuclear Cells |
| Q51705008 | Severe immune dysfunction after lethal neutron irradiation in a JCO nuclear facility accident victim. |
| Q73288178 | Short‐term liquid storage of umbilical cord blood |
| Q57121572 | Single centre experience of umbilical cord stem cell transplantation for primary immunodeficiency |
| Q33627040 | Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unit |
| Q57093531 | Small-Molecule Ice Recrystallization Inhibitors Improve the Post-Thaw Function of Hematopoietic Stem and Progenitor Cells |
| Q43621901 | Stem cell collection filter system for human placental/umbilical cord blood processing |
| Q39095853 | Stem cell transplantation during cancer |
| Q42923600 | Stem cells expressing homing receptors could be expanded from cryopreserved and unselected cord blood |
| Q34655280 | Stem cells for obstetricians and gynecologists |
| Q51682318 | Successful umbilical cord blood stem cell transplantation for chronic granulomatous disease. |
| Q44351342 | Successful unrelated cord blood transplantation in two children with severe combined immunodeficiency syndrome |
| Q92561161 | Thawing methods do not affect cell viability of CD45+ and CD34+ cells, but long-term cryopreservation of umbilical cord blood units generally decreases cell viability |
| Q39246024 | The Assessment of Parameters Affecting the Quality of Cord Blood by the Appliance of the Annexin V Staining Method and Correlation with CFU Assays. |
| Q36050021 | The Cord Blood Apgar: a novel scoring system to optimize selection of banked cord blood grafts for transplantation (CME). |
| Q33618635 | The cord blood separation league table: a comparison of the major clinical grade harvesting techniques for cord blood stem cells. |
| Q73828902 | The frequency and proliferative potential of megakaryocytic colony-forming cells (Meg-CFC) in cord blood, cytokine-mobilized peripheral blood and bone marrow, and their correlation with total CFC numbers: implications for the quantitation of Meg-CFC |
| Q50260263 | The induction and cryopreservation of erythroid progenitor cells derived from umbilical cord blood mononuclear cells |
| Q37788413 | The intra-bone marrow injection of cord blood cells extends the possibility of transplantation to the majority of patients with malignant hematopoietic diseases |
| Q34483172 | The role and potential of umbilical cord blood in an era of new therapies: a review |
| Q36375965 | The use of hydroxy-ethyl starch sedimentation for autologous buffy coat preparation. |
| Q90208060 | Therapeutic mechanism of cord blood mononuclear cells via the IL-8-mediated angiogenic pathway in neonatal hypoxic-ischaemic brain injury |
| Q44973647 | Transplantation of unrelated placental blood cells in children with high-risk sickle cell disease |
| Q37191911 | Transplantation perspectives in umbilical cord blood banks |
| Q36501354 | Trends in haematopoietic cell transplantation for inborn errors of metabolism |
| Q74462308 | Umbilical cord blood banking for unrelated transplantation: evaluation of cell separation and storage methods |
| Q33216669 | Umbilical cord blood banking: implications for perinatal care providers. |
| Q38510475 | Umbilical cord blood donation: public or private? |
| Q34178470 | Umbilical cord blood for allogeneic transplantation in children and adults |
| Q44121507 | Umbilical cord blood processing using Prepacyte-CB increases haematopoietic progenitor cell availability over conventional Hetastarch separation |
| Q54427086 | Umbilical cord blood progeny cells that retain a CD34+ phenotype after ex vivo expansion have less engraftment potential than unexpanded CD34+ cells. |
| Q92381702 | Umbilical cord blood quality and quantity: Collection up to transplantation |
| Q41470967 | Umbilical cord blood stem cells: application for the treatment of patients with hemoglobinopathies |
| Q37098276 | Umbilical cord blood therapy potentiated with erythropoietin for children with cerebral palsy: a double-blind, randomized, placebo-controlled trial |
| Q36059652 | Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease |
| Q74302237 | Umbilical cord blood transplantation for Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI) |
| Q73497741 | Umbilical cord blood transplantation in severe T-cell immunodeficiency disorders: two-year experience |
| Q38113482 | Umbilical cord blood transplantation: review of factors affecting the hospitalized patient |
| Q83557586 | Unrelated cord blood transplantation for thalassaemia: a single-institution experience of 35 patients |
| Q33451139 | Unrelated cord blood transplantation in CML: Japan Cord Blood Bank Network analysis |
| Q43613017 | Unrelated donor cord blood transplantation in adults with chronic myelogenous leukemia: results in nine patients from a single institution |
| Q36915945 | Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes. |
| Q36928836 | Update on umbilical cord blood transplantation |
| Q53653755 | Use of nonvolume-reduced (unmanipulated after thawing) umbilical cord blood stem cells for allogeneic transplantation results in safe engraftment. |
| Q44840436 | Validation of cord blood split products prepared by an automated method |
| Q33452165 | Viability and functional capacity after thawing of hematopoietic progenitor cells cryopreserved at a cord blood stem cell bank in Colombia |
Search more.